Novel substituted azabenzoxazoles

Details for Australian Patent Application No. 2009260519 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Sur, Cyrille; Mulhearn, James; Wolkenberg, Scott; Williams, David L.; Harrison, Scott; Barrow, James C.

Agent Spruson & Ferguson

Pub. Number AU-A-2009260519

PCT Pub. Number WO2009/155017

Priority 61/198,022 31.10.08 US; 61/130,399 30.05.08 US

Filing date 28 May 2009

Wipo publication date 23 December 2009

International Classifications

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4353 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

16 December 2010 PCT application entered the National Phase

  PCT publication WO2009/155017 Priority application(s): WO2009/155017

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009260525-Graduation function for stored value card

2009260517-Anti-FLT3 antibodies